First, we construct CRC cell model systems to assess the applicability of APA treatment in cases where the tumor is left with the slow NAT2 alleles belonging to the groups NAT2*5, NAT2*7 and NAT2*14. Here, NAT2 is linked to colorectal carcinoma.